Skip to main content
Clinical Trials/ISRCTN33276681
ISRCTN33276681
Active, not recruiting
未知

The clinical and cost-effectiveness of elective primary total knee replacement with PAtellar Resurfacing compared to selective patellar resurfacing. A pragmatic multicentre randomised controlled Trial with blinding (PART)

orth Bristol NHS Trust0 sites530 target enrollmentFebruary 27, 2023

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
orth Bristol NHS Trust
Enrollment
530
Status
Active, not recruiting
Last Updated
last year

Overview

Brief Summary

2024 Protocol article in https://pubmed.ncbi.nlm.nih.gov/38828864/ (added 04/06/2024)

Registry
who.int
Start Date
February 27, 2023
End Date
March 31, 2026
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
orth Bristol NHS Trust

Eligibility Criteria

Inclusion Criteria

  • 1\. 18 years of age or older
  • 2\. Elective primary Total Knee Replacement (TKR) for primary Osteoarthritis (OA)
  • 3\. Resident of England (English postcode) and surgery in an NHS England hospital

Exclusion Criteria

  • 1\. Revision TKR
  • 2\. Unicompartmental knee replacement
  • 3\. Primary TKR with:
  • 3\.1\. need for constrained implants (e.g., constrained condylar or hinge),
  • 3\.2\. isolated patellofemoral OA,
  • 3\.3\. history of septic arthritis,
  • 3\.4\. diagnosis other than primary OA
  • 4\. Intra\-operative patellar thickness insufficient for safe patellar resurfacing as determined by the treating surgeon (patellar thickness will be recorded in the case report forms for monitoring purposes)
  • 5\. Patient unable/unwilling to adhere to trial procedures
  • 6\. Patient unable to provide written informed consent.

Outcomes

Primary Outcomes

Not specified

Similar Trials